Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chronetyx Laboratories provides clinically validated, FDA-cleared and CE-IVD-marked advanced genomic and molecular diagnostics for cancer and infectious diseases, including comprehensive next-generation sequencing of solid tumors (Cyx Solid Tumor 505), high-throughput qPCR-based testing, and automated, actionable reporting integrated with clinical workflows. Their platform accelerates turnaround times and result accuracy, supporting oncology care and infectious disease management.[1][2][3][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chronetyx Laboratories.